NCT07206264 2025-10-03ADAPT-MCLTianjin Medical University Cancer Institute and HospitalPhase 2 Not yet recruiting45 enrolled
NCT06656221 2024-11-19A Prospective, Single-Center Study Evaluating the Efficacy and Safety of Glofitamab Combined With Orelabrutinib and Bortezomib in Patients With High-Risk Mantle Cell LymphomaRuijin HospitalPhase 2 Not yet recruiting29 enrolled